Abraham Chaibi is cofounder and CEO of Sapho Bio. The San Carlos company automates qc workflows for pharmaceutical companies. Its rapid sterility method returns results in 2 days, compared with 14 for the standard USP<71> method.
He arrived at biotech through software. As cofounder and CTO of Dexterity Capital from 2017 to 2024, he led the engineering behind the firm's low-latency trading platform. Earlier, he built data systems at LiveRamp and worked on optimization problems, NFL scheduling among them, for an analytics consultancy.
Abraham holds a BSE in mechanical engineering, cum laude. He is a licensed pilot.
Cofounded a high-frequency crypto trading firm and led the engineering behind its low-latency trading platform. Wrote more than 100,000 lines of automated trading software that traded more than $2 trillion, and managed $300 million across dozens of exchanges with millisecond response times. Built a team of more than 30 engineers and traders, and deployed a 10,000-core data center that cut model-fitting costs by 90% compared with cloud providers.
